drugset / Trial / NCT04415983

Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children

NCT04415983

Phase 3 Recruiting 100 enrolled Tanta University
RandomizedParallel-groupTriple-blindTreatment

Summary

Study of Nitazoxanide (NTZ) based therapeutic regimens for Helicobacter pylori in children

Timeline

Start
2020-06-01
Primary completion
2030-10-01
Completion
2030-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metronidazole Small molecule
Subject Nitazoxanide Other / unclassified
Background Clarithromycin Small molecule